A detailed history of Exchange Traded Concepts, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 12,245 shares of TYRA stock, worth $285,798. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,245
Previous 16,053 23.72%
Holding current value
$285,798
Previous $263,000 25.86%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$14.45 - $20.22 $55,025 - $76,997
-3,808 Reduced 23.72%
12,245 $195,000
Q1 2024

Apr 15, 2024

BUY
$11.61 - $20.0 $75,720 - $130,440
6,522 Added 68.43%
16,053 $263,000
Q4 2023

Jan 05, 2024

BUY
$11.01 - $14.95 $26,611 - $36,134
2,417 Added 33.98%
9,531 $132,000
Q3 2023

Oct 18, 2023

SELL
$13.15 - $16.08 $23,051 - $28,188
-1,753 Reduced 19.77%
7,114 $97,000
Q2 2023

Jul 20, 2023

BUY
$11.99 - $17.51 $106,315 - $155,261
8,867 New
8,867 $151,000

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $980M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.